DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 1.06% to $5.60 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.56% to 18,518.61 and the Dow Jones Industrial Average falling 0.61% to 42,114.40.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed $9.15 below its 52-week high ($14.75), which the company achieved on April 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 1.70% to $160.88, Statera Biopharma Inc. (STAB) rose 100.00% to $0.00, and Pfizer Inc. $(PFE)$ fell 0.66% to $28.45.
Trading volume (223,274) remained 77,707 below its 50-day average volume of 300,981.
Data source: Dow Jones Market Data, FactSet. Data compiled October 25, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 25, 2024 17:27 ET (21:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.